Equity Profile

ZLAB

Zai Lab Limited

Health CareBiotechnology$2.2B

Nov29Thu

Pre-Earnings Brief

UpcomingQ2-2026After Close9:00 AM EST

Company Snapshot

Zai Lab Limited is a biotechnology company focused on developing and commercializing innovative medicines in the healthcare sector. With a market cap of $2 billion, it plays a crucial role in addressing unmet medical needs, particularly in oncology and autoimmune diseases.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market presence and commercialize its products effectively.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

ZLAB Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

50%

Avg EPS Surprise

+0.83%

Avg Stock Reaction

-3.30%

Last Quarter Recap

In Q1-2026, Zai Lab reported an EPS of -$0.46, which was better than the expected -$0.58, resulting in a positive surprise of 20.69%. However, the stock declined by 5.93% the following day, indicating mixed investor sentiment.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall expectations for Zai Lab's upcoming earnings report are uncertain due to the lack of analyst estimates and management guidance. Investors are keen to see if the company can continue to improve its EPS and revenue metrics.

Bull Case

If Zai Lab can report a smaller-than-expected loss or even a surprise profit, it may signal strong operational performance and increased investor confidence.

Bear Case

Conversely, if the company reports a larger loss than anticipated or fails to show revenue growth, it could lead to further declines in stock price and investor sentiment.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for this quarter?

Given the company's recent performance and the mixed reactions to past earnings, the EPS will be a critical factor in determining market sentiment.

How is Zai Lab's revenue growth tracking?

Revenue growth is essential for assessing the company's market position and ability to sustain operations, making it a key focus for investors.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Zai Lab's potential for a smaller EPS loss due to recent operational improvements and product pipeline advancements.

Supporting Evidence

Zai Lab has shown a consistent ability to beat EPS estimates in the past, suggesting potential for another positive surprise.

The options market is pricing in a significant move, indicating that investors are anticipating volatility that could favor a positive outcome.

Key Risk

If the EPS loss comes in below $0.40, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is closely watching Zai Lab's ability to improve its financial metrics, especially in light of its recent performance and the broader biotechnology landscape.

Bull Confirmed If

Reporting an EPS loss of less than $0.40 would indicate improved financial health and operational efficiency.

Bear Confirmed If

An EPS loss greater than $0.50 would raise concerns about the company's profitability and future growth prospects.

Pre-Earnings Positioning

Options Market

Implied Move

±32.08%

Historical Avg

±5.0%

Pricing rich

The options market is pricing in a significant potential move, suggesting that investors expect considerable volatility around the earnings announcement.

Options are pricing ±32.1% while ZLAB has averaged ±5.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

60.2%

Calls (400)P/C Ratio: 52.33Puts (5K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Zai Lab beats expectations and raises guidance, history suggests the stock could rise by an average of 5.5% on the day.

In-Line / Cautious

If the results are in line with expectations but management provides cautious commentary, the stock may experience a muted reaction.

Miss

If the company misses expectations, history suggests a potential decline of around 1.1% on the following day.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on product pipeline advancements or approvals.
2Management's commentary on revenue growth expectations for the upcoming quarters.
3Insights into cost management strategies and their impact on profitability.
4Details on market expansion efforts and partnerships.
5Any changes in guidance or outlook for the next fiscal year.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

The Buckle, Inc.

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market presence and commercialize its products effectively.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

ZLAB Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

50%

Avg EPS Surprise

+0.83%

Avg Stock Reaction

-3.30%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If Zai Lab can report a smaller-than-expected loss or even a surprise profit, it may signal strong operational performance and increased investor confidence.

Bear Case

Conversely, if the company reports a larger loss than anticipated or fails to show revenue growth, it could lead to further declines in stock price and investor sentiment.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for this quarter?

Given the company's recent performance and the mixed reactions to past earnings, the EPS will be a critical factor in determining market sentiment.

How is Zai Lab's revenue growth tracking?

Revenue growth is essential for assessing the company's market position and ability to sustain operations, making it a key focus for investors.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Zai Lab's potential for a smaller EPS loss due to recent operational improvements and product pipeline advancements.

Supporting Evidence

Zai Lab has shown a consistent ability to beat EPS estimates in the past, suggesting potential for another positive surprise.

The options market is pricing in a significant move, indicating that investors are anticipating volatility that could favor a positive outcome.

Key Risk

If the EPS loss comes in below $0.40, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is closely watching Zai Lab's ability to improve its financial metrics, especially in light of its recent performance and the broader biotechnology landscape.

Bull Confirmed If

Reporting an EPS loss of less than $0.40 would indicate improved financial health and operational efficiency.

Bear Confirmed If

An EPS loss greater than $0.50 would raise concerns about the company's profitability and future growth prospects.

Pre-Earnings Positioning

Options Market

Implied Move

±32.08%

Historical Avg

±5.0%

Pricing rich

The options market is pricing in a significant potential move, suggesting that investors expect considerable volatility around the earnings announcement.

Options are pricing ±32.1% while ZLAB has averaged ±5.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

60.2%

Calls (400)P/C Ratio: 52.33Puts (5K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Zai Lab beats expectations and raises guidance, history suggests the stock could rise by an average of 5.5% on the day.

In-Line / Cautious

If the results are in line with expectations but management provides cautious commentary, the stock may experience a muted reaction.

Miss

If the company misses expectations, history suggests a potential decline of around 1.1% on the following day.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on product pipeline advancements or approvals.
2Management's commentary on revenue growth expectations for the upcoming quarters.
3Insights into cost management strategies and their impact on profitability.
4Details on market expansion efforts and partnerships.
5Any changes in guidance or outlook for the next fiscal year.